Husam Younis - 26 Feb 2026 Form 3 Insider Report for Atrium Therapeutics, Inc.

Role
Chief Scientific Officer
Signature
/s/ Adam Grajewski, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
3
Filing time
26 Feb 2026, 18:11:31 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Younis Husam Chief Scientific Officer C/O ATRIUM THERAPEUTICS, INC., 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO /s/ Adam Grajewski, Attorney-in-Fact 26 Feb 2026 0002107586

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Common Stock 22,657 26 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney